Outcome and follow-up
Subsequently, the patient was observed in intensive care unit for one
month. From February 21 to February 23 , the patient
developed a slight nausea, which resolved after the injection 40 mg of
esomeprazole. Then the patient developed a mild rash in February
29 , which gradually improved after the given of compound polymyxin B
ointment.
PET-CT
results in March 9 revealed that the patient was in lymphoma
remission and the PET 5-point scale (Deauville criteria) was 2. Then the
patient received four cycles of AVD chemotherapy (doxorubicin 80 mg,
vindesine 4 mg and dacarbazine 700 mg). During the treatment and
one-year follow-up period, the function of lung, liver, kidney and heart
in this patient was basically normal. The timeline of the patient’s
management and outcome is presented in Figure 1 .